iTolerance
Share
iTolerance is a privately held regenerative medicine company enabling tissue, organoid or cell therapy without the need for life-long immunosuppression.
08/28/2026
At iTolerance, we're advancing data-driven regenerative medicine with the goal of enabling tissue, organoid and cell therapies without the need for lifelong immunosuppression.
8.75 million people worldwide live with Type 1 Diabetes, yet many continue to face significant challenges despite insulin therapy.
iTolerance is advancing innovative approaches with the goal of transforming treatment.
08/07/2026
Be part of the journey.
Subscribe to iTolerance's email alerts for the latest updates as we work to advance innovative therapies for patients with type 1 diabetes.
Sign up: https://bit.ly/3PYFAqw
An estimated 100K–135K people live with brittle Type 1 Diabetes, a severe form of the disease marked by dangerous blood sugar swings that can lead to seizures, coma, heart attacks and even death.
The unmet need remains significant.
07/22/2026
Be the first to hear what’s next at iTolerance.
Subscribe for email alerts and stay informed on the latest milestones, scientific progress and company developments.
Sign up: https://bit.ly/3PYFAqw
07/13/2026
At iTolerance, our values guide everything we do, from integrity and accountability to respect and teamwork.
Together, we are committed to advancing innovation while working to improve patients’ lives.
07/04/2026
Today, we celebrate 250 years of American independence and the freedoms that unite us.
From all of us at iTolerance, we wish you a safe, happy and meaningful Fourth of July.
06/22/2026
Get the latest updates from iTolerance delivered directly to your inbox.
Sign up for email alerts to stay informed on company news, research progress and updates.
https://bit.ly/3PYFAqw
Even with insulin treatment, there remains a significant unmet need in Type 1 Diabetes.
Approximately 1.6 million adults over the age of 20 in the U.S. are living with T1D. We are working to improve these numbers.
06/05/2026
Innovation. Expertise. Breakthroughs.
iTolerance is a patient-first, data-driven regenerative medicine company focused on developing potential cures that improve the lives of people living with chronic conditions.
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
1951 NW 7th Avenue
Miami, FL
33136